Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2541703 | International Immunopharmacology | 2007 | 12 Pages |
Abstract
Increasing evidence is now available showing that CD1-restricted T cell responses against non-peptide mycobacterial antigens could play a role in the immune resistance against tuberculosis. BCG, widely used in anti-tubercular vaccination, shares various constituents with Mycobacterium tuberculosis, but does not provide full protection. In the present study we have investigated the pattern of group 1 CD1 molecule expression in adherent mononuclear cells (AMNC) of human peripheral blood, infected in vitro with BCG. Shortly after exposure to BCG, both BCG-positive and BCG-negative AMNC showed a moderate CD1 expression elicited by BCG-induced release of GM-CSF presumably acting through an autocrine and a paracrine mechanism. This was demonstrated using two-color flow cytometry with green fluorescent BCG and anti-CD1 PE-labeled antibodies. However, high CD1 expression induced by exogenously added GM-CSF in AMNC was reduced if target cells were cocultivated with BCG. Monoclonal antibodies against IL-10 partially restored CD1 expression, thus showing that IL-10, released from infected AMNC, is involved, at least in part, in CD1 negative modulation. Therefore, through a complex cytokine network, including not yet identified factor(s), BCG triggers but does not allow full expression of CD1 on AMNC. It cannot be excluded that this mechanism could play a role in the limited efficiency of BCG vaccination.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Salvatore Pasquale Prete, Anna Giuliani, Stefania D'Atri, Grazia Graziani, Alessandra Balduzzi, Marco Rinaldo Oggioni, Elisabetta Iona, Giampiero Girolomoni, Laura Bonmassar, Luigina Romani, Ornella Franzese,